WA
Wanbury Limited
WANBURY.NS · NSE
₹239.00 -1.01% (-₹2.45)
1M -4.68%
Market Cap ₹8.41B
P/E Ratio 15.04x
Div. Yield -
ROE 53.46%
Bulios Fair Price
₹191.35
19.9% downside
Trenutna cena
₹239
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica WANBURY.NS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
74 /100
Cheap P/E 15.04x
PEG 0.11x
EV/EBITDA 11.07x
Growth
64 /100
Stable Rev. growth 9.29%
EPS growth N/A
Book val. growth N/A
Profitability
44 /100
Moderate Gross margin 40.54%
FCF margin 3.80%
Net margin 8.56%
Quality
99 /100
Excellent ROIC 23.56%
Asset turnover 1.26x
ROE 53.46%
Debt
43 /100
Moderate Debt/Equity 1.55x
Net debt/EBITDA 2.27x
Current ratio 1.19x
Stability
52 /100
Moderate Beta 1.26x
Profitable years 3
Rev. volatility 5.54%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o WANBURY.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Pradeep Patni
Employees
1,491
Headquarters
Navi Mumbai
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report